Sanofi's stock and future outlook are being discussed, with some outlets providing forecasts and analysis of the company's potential. The company's pipeline and vaccine sales are also being examined, with potential challenges from us policy shifts noted. Sanofi's research and development strategy is being defended by its chief, amid discussions of the company's position among major pharmaceutical companies.